Vistagen files new corporate presentation; no material updates disclosed

Vistagen Therapeutics, Inc.

Filed 8-K to announce use of updated corporate presentation dated March 2026.
Presentation covers pipeline and strategy but no specific financial or clinical data provided.
No earnings, guidance, or operational milestones were released in this filing.

item 7.01 item 9.01

Vistagen Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-26-018163

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.